Calibrating a network meta-analysis of diabetes trials of sodium glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population : a systematic review protocol

Butterly, Elaine, Wei, L, Adler, Amanda I et al. (16 more authors) (2022) Calibrating a network meta-analysis of diabetes trials of sodium glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population : a systematic review protocol. BMJ Open. e066491. ISSN 2044-6055

Metadata

Authors/Creators:
  • Butterly, Elaine
  • Wei, L
  • Adler, Amanda I
  • Almazam, S A
  • Alsallumi, K
  • Blackbourn, L
  • Dias, Sofia ORCID logo https://orcid.org/0000-0002-2172-0221
  • Hanlon, Peter
  • Hughes, K A
  • Lewsey, J
  • Lindsay, R S
  • McGurnaghan, S
  • Petrie, J R
  • Phillippo, David M
  • Sattar, N
  • Tomlinson, L
  • Welton, Nicky J
  • Wild, S H
  • McAllister, David A.
Copyright, Publisher and Additional Information: © Author(s) (or their employer(s)) 2022
Dates:
  • Accepted: 26 September 2022
  • Published: 27 October 2022
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
Funding Information:
FunderGrant number
MEDICAL RESEARCH COUNCIL (MRC)MR/T017112/1
Depositing User: Pure (York)
Date Deposited: 06 Oct 2022 13:00
Last Modified: 06 Dec 2023 14:53
Published Version: https://doi.org/10.1136/bmjopen-2022-066491
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1136/bmjopen-2022-066491

Download

Filename: e066491.full.pdf

Description: Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol

Licence: CC-BY 2.5

Export

Statistics